News
 |
31 May 2022
HKU medical research team starts large-scale clinical trial on COVID-19 Vaccine (Omicron Variant) |
 |
17 March 2022
A collaboration study led by HKUMed finds that patients with treatment-resistant depression (TRD) have greater risk of mortality and healthcare costs; calls for early and subsequent clinical monitoring |
 |
26 January 2022
HKUMed researchers identified a key molecule in extracellular vesicles of liver cancer patient as a potential new biomarker for early diagnosis and therapeutic target |
 |
12 April 2021
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target |
 |
10 February 2021
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target |
 |
09 October 2020
HKUMed reports a simple risk score to identify undiagnosed diabetes and announces the launch of the “HK CRISPS Health Risk Engines” Smartphone App |
 |
04 August 2020
HKUMed researchers first discovered SARS-CoV-2 infects human neural progenitor cells and brain organoids |
 |
03 June 2020
HKUMed discovers a novel mediator of cerebral ischaemia injury and its underlying mechanism which can be a new therapeutic target for ischaemic stroke |
 |
15 April 2020
HKUMed research shows that stroke patients are presenting to hospitals one hour later during COVID-19, potentially jeopardising the patients’ eligibility for treatments and affecting the outcome |
 |
05 March 2019
HKU Studies the Prevalence of Viral Hepatitis in HK – The First Largest Population Territory-based Study Identifies Areas of Need in Combating Liver Diseases |
 |
25 April 2018
The research team of Department of Medicine, HKU, and Department of Surgery, North District Hospital (NDH),identify long-term Ketamine abuse damages the biliary system |
 |
18 April 2018
HKU team led by Professor David SIU Chung-wah Discovers the Application of Human Induced Pluripotent Stem Cells in Precision Medicine for Hereditary Diseases |
 |
30 November 2017
HKU and International Collaborative Research Teams Discover Novel Genetic Markers for Blood Lipids and Coronary Artery Disease |
 |
13 November 2017
HKU Finds that Long-term Use of Proton Pump Inhibitors is Associated with an Increased Risk of Stomach Cancer |
 |
14 September 2017
HKU Identifies HBV Treatment Reduces Liver Cancer Incidence in Hong Kong Recommends Strengthening Community Outreach to Reduce Number of Liver Cancer Patients |
 |
20 April 2017
HKU research team led by Prof HF Tse Develops Chimeric Mouse Liver Model Helps Familial Hypercholesterolemia Patients Test Drug Response |
 |
11 April 2017
HKU Discovers that Traditional Blood Thinner Drug is associated with a Higher Risk of Osteoporotic Fracture compared to Newer Drug |
 |
31 October 2016
HKU Identifies Homoharringtonine as Effective Treatment for FLT3 Mutant Acute Myeloid Leukaemia for the First Time in the World |
